Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial - Kalra, PR; Cleland, JGF; Petrie, MC (Lancet, 2023)
et al.